Artelo Biosciences, Inc..
ARTL.US | Research and experimental development on natural sciences and engineering
Artelo Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutics that modulate the endocannabinoid system. Their pipeline includes preclinical and clinical-stage programs targeting cancer, pain, and other conditions. The company's primary focus is on res...Show More
Better Health for All
10
Artelo Biosciences' core business is the research and development of therapeutics for serious conditions such as cancer cachexia, anxiety, depression, pain, and neurological conditions, addressing significant unmet medical needs.
1
All products in their pipeline are aimed at providing substantial health benefits, indicating 100% of their portfolio is dedicated to revolutionary health benefits. As a clinical-stage company, it has no revenue from commercialized products, and its pipeline consists solely of health-positive offerings.
2
The company is a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways, indicating a high investment in health innovation.
3
However, the company holds a US composition of matter patent for ART12.11, enforceable until December 10, 2038, and granted in 19 additional countries, which suggests limited patent flexibility.
4
Artelo Biosciences has received Ethics Committee approval in the U.K. for its CAReS clinical trial,
5
which is a randomized, placebo-controlled trial.
6
No specific quantitative data on adverse event rates, price accessibility, vulnerable reach, risk transparency, healthcare data responsibility, or mental health initiatives are provided to meet the rubric's thresholds for those KPIs.
Fair Money & Economic Opportunity
0
No evidence available to assess Artelo Biosciences, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence articles provided contain data relevant to ARTL.US (Artelo Biosciences, Inc.) for any of the Fair Pay & Worker Respect KPIs.
1
All provided articles pertain to Tesla or teslat.com and explicitly state that they do not contain information relevant to ARTL.US or the specified ethical value metrics.
2
Fair Trade & Ethical Sourcing
0
No specific, concrete data points were found in the provided articles for any of the Fair Trade & Ethical Sourcing KPIs. The articles primarily focus on financial reporting, clinical trials, and regulatory matters for a biopharmaceutical company. While the company relies on third-party manufacturers and sources cannabinoids for research,
1
no details regarding fair-trade certifications, ethical sourcing audit frequencies, forced or child labour incidents, supply chain traceability, remediation processes, ethical clauses in supplier contracts, high-risk materials, or supplier diversity spend are provided.
2
Honest & Fair Business
-40
Artelo Biosciences, Inc. has a formal whistleblower protection policy that includes multiple reporting options, such as email, letter, a third-party service provider (Lighthouse Services) with a hotline and website, and direct reporting to the Audit Committee.
1
The company also has an anti-corruption and anti-bribery policy that specifically addresses compliance with the Foreign Corrupt Practices Act (FCPA) and improper payments to government officials.
2
Kind to Animals
-60
Artelo Biosciences' research for drug candidates like ART26.12 and ART12.11 involves both in vitro and in vivo (animal) models, with in vitro toxicological effects observed for ART26.12.
1
The company explicitly states it uses animals for product testing as part of its traditional regulated drug development standards, including preclinical laboratory tests and animal studies in compliance with FDA’s Good Laboratory Practice regulations.
2
Animal studies have been conducted in rodents and dogs, with a no-observable-adverse-effect-level of 1000 mg/kg/day after 35 days in vivo.
3
The company collaborates with Stony Brook University for translational research in osteoarthritis models.
4
ART26.12 has been included in the U.S. National Institutes of Health’s HEAL Initiative’s Preclinical Screening Platform for Pain program,
5
but there is no public position on animal welfare legislation or active advocacy for higher standards.
No War, No Weapons
0
Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics.
1
The provided articles, including a company filing, explicitly state that they do not contain information related to any of the 'No War, No Weapons' metrics.
2
Therefore, no specific evidence is available to assess the company against these KPIs.
Planet-Friendly Business
0
No specific, quantitative data related to planet-friendly business metrics for Artelo Biosciences, Inc. (ARTL.US) is available in the provided articles. Multiple sources indicate that sustainability or ESG data for the company is either not mentioned or currently unavailable.
1
An SDG Transparency Score of 36.7 was noted,
2
but this is a measure of reporting transparency, not a direct environmental performance metric for any of the defined KPIs.
Respect for Cultures & Communities
0
No specific data or information regarding Artelo Biosciences' performance on 'Respect for Cultures & Communities' metrics is available in the provided articles.
1
The articles primarily focus on clinical trial updates or explicitly state the absence of sustainability data for the company,
2
preventing any assessment against the rubric's KPIs.
Safe & Smart Tech
0
The company's privacy policy, last updated in April 2017, states that users can opt-in or opt-out of providing information and have options to correct or update their data.
1
Zero Waste & Sustainable Products
0
No quantitative data related to waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education is provided in the available articles for Artelo Biosciences, Inc.
1
The information regarding packaging for a 'print-on-demand wall art business' is not explicitly stated to apply to the core biopharmaceutical operations of Artelo Biosciences, Inc. and lacks specific quantitative sustainability metrics.
2